Satellos Bioscience Inc.
MSCLF
$0.4284
$0.01934.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.63% | -37.68% | -74.71% | -96.28% | -79.43% |
| Total Depreciation and Amortization | 53.25% | 115.63% | 190.20% | -41.67% | -91.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 127.26% | 37.40% | -5.04% | 78.24% | -57.89% |
| Change in Net Operating Assets | -370.17% | -1,343.44% | -402.84% | 1,112.39% | 338.15% |
| Cash from Operations | -43.49% | -54.31% | -116.15% | -96.21% | -152.21% |
| Capital Expenditure | 75.41% | 79.17% | 70.15% | 62.99% | -87.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 207.36% | 146.84% | 141.19% | -- | -- |
| Cash from Investing | 207.22% | 146.77% | 141.11% | 5,789.76% | -188,606.15% |
| Total Debt Issued | -- | -- | -- | -93.76% | -93.81% |
| Total Debt Repaid | -- | -- | -- | 90.06% | -- |
| Issuance of Common Stock | 1,568.38% | 24.10% | 24.10% | -91.01% | -92.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 448.55% | -36.45% | -36.48% | -115.79% | -114.79% |
| Cash from Financing | 2,143.82% | 6.55% | 1.82% | -100.71% | -104.66% |
| Foreign Exchange rate Adjustments | 342.98% | 108.96% | 96.16% | -728.69% | 63.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 211.64% | 231.52% | 63.87% | -151.86% | -183.67% |